ksl-2
Peptideexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT01877421)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ksl-2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02864901 | Phase 2 | Jun 1, 2017 | Salus Research, United States Army |
| NCT01877421 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Indiana University, United States Army |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| United States Army | Government | 2 | 2 | 1 | 2014 |
| Indiana University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Salus Research | For profit | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1